flag flag  

Resistance testing in children changing human immunodeficiency virus type 1 protease inhibitor

Description : Objective. To assess genotypic and phenotypic resistance testing in HIV-1-infected children failing a first protease inhibitor (PI) therapy. Methods. In a multicenter observational study 21 children, ages 3 to 16 years, were given two reverse transcriptase inhibitors and one PI (mainly ritonavir, n ...
Language(s) : English
Subject(s) : human immunodeficiency virus type 1-infected , children , protease inhibitor resistance , nelfinavir , highly active antiretroviral therapy , cross-resistance , Human health sciences :: Immunology & infectious disease [D12] , Sciences de la santé humaine :: Immunologie & maladie infectieuse [D12]
Publisher(s) :
Contributor(s) :
Source(s) : &ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&date=2002&jtitle=Pediatric+Infectious+Disease+Journal&issn=0891-3668&volume=21&issue=3&pages=214-220&pub=Lippincott+Williams+%26+Wilkins&place=Philadelphia
Publication Date(s) : 2002-03-01